Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

06/04/2018 Stradivarius Counts On Omnichannel and Aitana Ocaña 21/03/2018 Sun and salt: SENER’s know-how 15/03/2018 Major Upgrade of an ALBA Synchrotron Beamline 01/03/2018 ALBA Synchrotron is as good at humanities as at sciences! 23/02/2018 Catalonia, 2018/19 Top Southern European Region for FDI Strategy 15/02/2018 ICMAB traps sunlight with superabsorbent nanomaterials
11 12 13 14 15 16 17 18 19 20 21